| Website | nexdx.com |
| info@nexdx.com | |
| Employees |
| TOTAL | $2.6M |
| FUNDING TOTAL | $2.6M |
| Series B, 6/12 City Hill Ventures Silicon Valley Bank | $2.6M |
NexDx is a science driven molecular diagnostics company providing next generation products and services for personalized medicine in autoimmune diseases. Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions for rheumatoid arthritis (RA) and other autoimmune diseases; and to discover truly novel and validate existing autoimmune disease targets for biopharmaceutical companies to enable the development of innovative targeted therapies for rheumatology patients.
